US Stock MarketDetailed Quotes
COEPW COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM)
- 0.021
- -0.001-4.55%
Close Apr 26 16:00 ET
0Market Cap0.00P/E (TTM)
0.024High0.021Low26.52KVolume0.023Open0.022Pre Close610.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.15252wk High0.00P/B0Float Cap0.01952wk Low--Dividend TTM0Shs Float1.740Historical High--Div YieldTTM15.91%Amplitude0.010Historical Low0.022Avg Price1Lot Size
COEPTIS THERAPEUTICS HOLDINGS INC C/WTS 31/12/2024 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -86.79%-7.24M | -99.89%-1.69M | -89.54%-1.96M | -84.12%-1.9M | -75.15%-1.68M | 13.67%-3.88M | -305.67%-847.35K | 71.69%-1.03M | -4,259.21%-1.03M | -46.77%-961.73K |
| Net income from continuing operations | 43.40%-21.27M | -27.61%-3.76M | -12.42%-6.35M | 67.33%-3.2M | 58.51%-7.96M | -179.38%-37.57M | -3.64%-2.94M | 5.01%-5.65M | -261.30%-9.8M | -883.53%-19.18M |
| Operating gains losses | -92.76%2.05M | -85.12%354.03K | -132.62%-1.09M | -96.54%286.5K | -82.46%2.5M | 429.58%28.26M | -2.30%2.38M | 45.76%3.36M | --8.28M | --14.25M |
| Depreciation and amortization | -0.01%1M | -0.01%250.31K | -0.01%250.31K | -0.01%250.31K | -0.01%250.31K | 123.82%1M | -43.89%250.35K | 68,300.55%250.35K | 68,114.17%250.35K | 51,946.99%250.35K |
| Other non cash items | 75.40%8.74M | 15.98%421.6K | 436.53%4.85M | 99.77%351K | -11.95%3.12M | 17.05%4.98M | -54.79%363.5K | 48.86%904.3K | -91.54%175.7K | 359.74%3.54M |
| Change In working capital | 420.10%1.76M | 201.05%907.35K | 156.52%271.02K | 362.45%298.63K | 60.48%284.64K | 81.53%-550.34K | 14.91%-897.93K | 104.21%105.65K | 3.61%64.58K | -66.17%177.37K |
| -Change in receivables | -282.70%-30.9K | ---38.15K | 89.68%-833 | --0 | --8.08K | -137.07%-8.08K | --0 | ---8.08K | --0 | --0 |
| -Change in prepaid assets | 118.50%90.76K | 102.86%14.03K | --41.84K | --14.17K | --20.71K | ---490.69K | ---490.69K | --0 | --0 | --0 |
| -Change in payables and accrued expense | 3,352.09%1.7M | 327.65%926.61K | 102.06%230.21K | 339.41%284.67K | 45.40%256.07K | 97.39%-52.2K | 62.42%-407.03K | 107.56%113.93K | -10.90%64.78K | -65.78%176.11K |
| -Change in other working capital | 573.25%4.23K | 2,432.21%4.85K | -0.48%-208 | 0.48%-207 | -116.63%-208 | 100.06%628 | 36.78%-208 | 99.98%-207 | 98.00%-208 | -87.14%1.25K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -86.79%-7.24M | -99.89%-1.69M | -89.54%-1.96M | -84.12%-1.9M | -75.15%-1.68M | 13.67%-3.88M | -305.67%-847.35K | 71.69%-1.03M | -4,258.20%-1.03M | -46.77%-961.73K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -350K | 0 | 0 | 0 | ||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --350K | ---350K | --0 | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10.39%4.92M | 164.10%1.75M | -103.73%-224.93K | 217.50%3.39M | 0 | -33.21%5.49M | 21.39%-2.73M | -29.96%6.03M | 77.49%1.07M | -54.73%1.13M |
| Net issuance payments of debt | 76.21%-575K | 90.55%-200K | -1,350.00%-725K | --350K | --0 | -48.98%-2.42M | 60.19%-2.12M | -101.05%-50K | --0 | -104.24%-250K |
| Net common stock issuance | 61.77%5.29M | 175,141,000.00%1.75M | -62.12%500.07K | 343.61%3.04M | --0 | -66.92%3.27M | -100.00%1 | -48.40%1.32M | -52.76%685.49K | -56.46%1.27M |
| Proceeds from stock option exercised by employees | -96.19%200K | 29,729.63%200K | --0 | --0 | --0 | --5.25M | ---675 | --4.76M | --382.5K | --107.5K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -1,107.50%-614.58K | ---- | ---- | --0 | 100.84%2.5K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10.39%4.92M | 164.10%1.75M | -103.73%-224.93K | 217.50%3.39M | --0 | -33.21%5.49M | 21.39%-2.73M | -29.96%6.03M | 77.49%1.07M | -54.73%1.13M |
| Net cash flow | ||||||||||
| Beginning cash position | 73.95%3.79M | -80.85%1.41M | 36.43%3.24M | -10.11%2.11M | 73.95%3.79M | 973.86%2.18M | 162.32%7.37M | 24.43%2.38M | 15.19%2.34M | 973.86%2.18M |
| Current changes in cash | -244.08%-2.32M | 101.61%57.62K | -136.72%-1.83M | 3,201.84%1.14M | -1,125.42%-1.68M | -18.46%1.61M | -467.92%-3.58M | 455.63%4.99M | 127.92%34.47K | -91.03%164.27K |
| End cash Position | -61.25%1.47M | -61.25%1.47M | -80.85%1.41M | 36.43%3.24M | -10.11%2.11M | 73.95%3.79M | 73.95%3.79M | 162.32%7.37M | 24.43%2.38M | 15.19%2.34M |
| Free cash flow | -86.79%-7.24M | -99.89%-1.69M | -89.54%-1.96M | -84.12%-1.9M | -75.15%-1.68M | 37.88%-3.88M | -129.78%-847.35K | 86.59%-1.03M | -42.53%-1.03M | -46.77%-961.73K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg